MedPath

se of novel lung injury markers to predict graft dysfunction after lung transplantatio

Completed
Conditions
10024967
chronic bronchitis
Chronic obstructive pulmonary disease
Registration Number
NL-OMON34782
Lead Sponsor
niversitair Medisch Centrum Groningen
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
38
Inclusion Criteria

Age ><= 18 years
First lung transplantation
Informed consent

Exclusion Criteria

Hyperacute rejection
Venous anastomotic obstruction
Cardiogenic pulmonary edema
Pneumonia (both viral and bacterial pneumonias will be considered)

Study & Design

Study Type
Observational invasive
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<p>The primary endpoint is primary graft dysfunction in the first 72 hours as<br /><br>defined by a classification system from the international society for heart and<br /><br>lung transplantation.</p><br>
Secondary Outcome Measures
NameTimeMethod
<p>1. Assessment of biomarkers, measured during and post operation (in the<br /><br>recipient), that correlates with the graft function after lung transplantation.<br /><br>2. Assessment of biomarkers, measured during and post operation (in the<br /><br>recipient), that quantifies primary graft dysfunction.</p><br>
© Copyright 2025. All Rights Reserved by MedPath